U.S. firm Eli Lilly unveils drug for obesity, diabetes
21
Mar
U.S. firm Eli Lilly unveils drug for obesity, diabetes Sub: Sci Sec: Health Context: American pharmaceutical giant Eli Lilly and Company introduced Mounjaro (tirzepatide) in India after receiving marketing authorization from the Central Drugs Standard Control Organisation (CDSCO). India has around 101 million people with diabetes. The growing demand for GLP-1 class drugs […]